Post-menopausal osteoporosis.
Marcus
Robert
R
Stanford University, CA 94304, USA.
D000293:Adolescent; D000328:Adult; D000368:Aged; D015519:Bone Density / Q000235:genetics; D001846:Bone Development / Q000235:genetics; D016723:Bone Remodeling / Q000502:physiology; D002118:Calcium / Q000627:therapeutic use; D004164:Diphosphonates / Q000627:therapeutic use; D015914:Estrogen Replacement Therapy; D004967:Estrogens / Q000502:physiology; D015444:Exercise; D005260:Female; D050723:Fractures, Bone / Q000517:prevention & control; D005838:Genotype; D006728:Hormones / Q000627:therapeutic use; D006801:Humans; D008593:Menopause; D008875:Middle Aged; D015663:Osteoporosis, Postmenopausal / Q000175:diagnosis / Q000188:drug therapy*; D010281:Parathyroid Hormone / Q000627:therapeutic use; D045167:Progesterone Congeners / Q000627:therapeutic use; D020845:Selective Estrogen Receptor Modulators / Q000627:therapeutic use; D014807:Vitamin D / Q000627:therapeutic use
D004164:Diphosphonates; D004967:Estrogens; D006728:Hormones; D010281:Parathyroid Hormone; D045167:Progesterone Congeners; D020845:Selective Estrogen Receptor Modulators; D014807:Vitamin D; D002118:Calcium